Gm14431 Inhibitors
Gm14431 inhibitors are a chemical class of compounds known for their role in selectively modulating the activity of the Gm14431 protein or its associated pathways. The Gm14431 protein is involved in various biological processes, and its function is tightly regulated within the cellular environment. Inhibitors of Gm14431 are typically small molecules or peptides designed to bind specifically to active or regulatory sites of the Gm14431 protein, blocking its activity or altering its structural conformation to reduce its biological function. The specificity of these inhibitors is a critical feature, as it allows for targeted modulation of Gm14431 without significantly affecting other proteins or pathways, thus reducing off-target interactions.
The chemical structure of Gm14431 inhibitors varies depending on their mode of action and the particular aspect of the protein they target. Many of these inhibitors contain structural motifs that enable them to fit into the protein's binding pockets or interact with allosteric sites, thereby disrupting protein-protein interactions or catalytic activities. These compounds can vary widely in their size, polarity, and binding affinities, allowing researchers to tailor their properties for optimal interaction with the Gm14431 protein. The development and study of these inhibitors are of significant interest in understanding the biological role of Gm14431 in various cellular processes. By examining the binding properties, stability, and specificity of different Gm14431 inhibitors, researchers can further elucidate the structural and functional characteristics of the Gm14431 protein and its regulatory mechanisms within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is a histone deacetylase inhibitor that can lead to an open chromatin structure around the promoter region of specific genes. This could downregulate Gm14431 by allowing transcription repressors to bind more easily to the gene's promoter. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine could cause demethylation of the Gm14431 promoter, which may lead to the binding of transcriptional repressors, thereby leading to a decrease in the expression of transmembrane protein 60. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound binds to DNA at the transcription initiation complex and prevents the elongation of RNA chains by RNA polymerase, which would decrease the synthesis of mRNA for Gm14431, thereby reducing protein expression levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide blocks the translocation step in eukaryotic protein synthesis on ribosomes, which would result in a decrease in overall protein synthesis, including the synthesis of transmembrane protein 60 encoded by Gm14431. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin would inhibit the mTOR pathway, which is crucial for cap-dependent translation initiation. This action could specifically decrease the translation efficiency of the mRNA transcript of Gm14431. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the ubiquitin-proteasome pathway, leading to the accumulation of ubiquitinated proteins and potential cellular stress. This stress might trigger a specific decrease in the expression of Gm14431 as a cellular response. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts lysosomal acidification, which can result in diminished lysosomal protein degradation. This may indirectly decrease the turnover of membrane proteins, including those encoded by Gm14431, potentially increasing their cellular levels but decreasing their synthesis as a compensatory mechanism. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid binds to retinoic acid receptors, which can alter the transcription of genes involved in cell differentiation. This could lead to the downregulation of Gm14431 if it is part of a differentiation pathway that is inhibited by retinoic acid. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 would inhibit the c-Jun N-terminal kinase pathway, which could result in downregulation of Gm14431 if the protein product is dependent on JNK signaling for its expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a specific inhibitor of PI3K, which could lead to decreased activity of the downstream AKT signaling pathway. This could result in reduced transcriptional activity of genes like Gm14431 that may rely on this pathway for expression. | ||||||